Packaging contractor Helvoet places stake in Asia; Merck, Emergent add staff;

> Belgium-based parenterals packager Helvoet Pharma is building a $26.5 million plant in India, expected to open in 2012, to establish an Asian presence. Story

> Merck has been adding staff to its vaccine manufacturing plant in Durham, NC, and expects to hire an additional 310 people over the next two years. Article

> Maryland-based Emergent Biosolutions continues to grow in Lansing, MI, as it ramps up production for its anthrax vaccine. News

> European CMO NextPharma says it has passed an inspection by Japanese regulator PMDA resulting in continued accreditation of its Brussels-area Braine-l'Alleud facility, used in aseptic production and the manufacture of cytotoxic products. Article

> Meridian Life Science of Memphis has completed a second clinical cGMP production lot of the live oral RV3 rotavirus vaccine candidate. Report

> Reliable Biopharmaceutical in St. Louis has named David Feldker its CEO and president, effective next month. Reliable release

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.